2509.HK

Qyuns Therapeutics Co., Ltd.
HKSEHKDEQUITY Healthcare DELAYED
Last price
16.88
▼ 0.09 (0.53%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
16.97
Prev close
16.97
Day high
17.00
Day low
16.53
Volume
8.40K
Market cap
$3.77B
P/E (TTM)
5.92
52W range
13.21 – 36.50

Day trading desk

Current session · delayed
Gap from prior close
0.00%
Prior close 16.97
VWAP
16.75
+0.77% from price
Relative volume
0.10×
Quiet session
Session range
2.84%
16.53 – 17.00
Position in range
74%
Near session high
ATR (14D)
0.83
4.89% of price
Prior day high
17.04
PDH
Prior day low
16.58
PDL
Bid / ask spread
Quote not published
Session volume
16.40K
Avg 165.58K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-5.96% -4.8%
1M
+4.20% +0.8%
3M
+8.69% +6.3%
6M
-18.22% -30.1%
YTD
-11.62% -23.6%
1Y
-22.92% -43.1%
3Y
-75.0%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

11 more panels on 2509.HK open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
134.49M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Mar 27, 25
Qiu (Jiwan)
Chief Executive Officer
10.00M Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

1 reporting
NameRelationShares heldLatest
Qiu (Jiwan)
Chief Executive Officer 10.00M Other

Fundamentals

TTM · reported
Market cap$3.77B
Enterprise value$3.44B
Revenue (TTM)$1.02B
Gross profit$908.13M
EBITDA$589.59M
Net income$546.10M
EPS (TTM)$2.85
Free cash flow$316.99M
Total cash$1.02B
Total debt$686.51M
Book value / share$4.50
Shares outstanding223.37M
Float105.60M
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E5.92
Forward P/E26.96
PEG ratio
Price / sales
Price / book3.75
EV / revenue3.36
EV / EBITDA5.84
Gross margin88.64%
Operating margin49.61%
Profit margin53.30%
Return on equity101.58%
Return on assets22.97%
Debt / equity81.60
Current ratio2.29
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 3 quarters
Blank means not reported, not zero
Line item20252024202320222021YoY
Total revenue $806.96M$158.79M$0$0 +408.2%
Operating revenue $806.96M$158.79M$0$0 +408.2%
Cost of revenue $92.55M$66.60M$0 +39.0%
Gross profit $714.41M$92.19M$0 +674.9%
Research & development $253.17M$334.28M$364.40M$257.21M -24.3%
Selling, general & admin $130.40M$116.85M$164.59M$76.60M +11.6%
Total operating expense $381.20M$434.42M$515.40M$324.62M -12.3%
Operating income $333.21M-$342.22M-$515.40M-$324.62M +197.4%
Net interest income -$13.65M-$15.61M-$12.36M-$14.53M +12.6%
Pre-tax income $307.37M-$349.76M-$521.33M-$312.38M +187.9%
Tax provision -$73.00K-$73.00K-$73.00K-$73.00K 0.0%
Net income $314.45M-$335.57M-$507.75M-$298.19M +193.7%
Net income to common $314.45M-$335.57M-$507.75M-$298.19M +193.7%
Basic EPS -1.53-2.29-1.34-1.85
Diluted EPS -1.53-2.29-1.34-1.85
EBIT $326.59M-$326.37M-$504.51M-$293.69M +200.1%
EBITDA $358.69M-$293.70M-$472.23M-$263.15M +222.1%
Basic shares 219.44M222.07M222.07M222.07M
Diluted shares 219.44M222.07M222.07M222.07M

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year 1.00 1 $535.00M -33.7%
Next year 0.63 1 $512.00M -4.3%

Analyst targets & ownership

Account required
Mean target$33.00
High target$33.00
Low target$33.00
Implied upside95.50%
Analyst count1
ConsensusSTRONG BUY
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders60.19%
Held by institutions0.73%
Institutions holding9
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
17.35
-2.73% from price
SMA 20
16.90
-0.13% from price
SMA 50
15.92
+6.04% from price
SMA 100
16.84
+0.26% from price
SMA 200
18.44
-8.45% from price
EMA 12
17.05
-1.01% from price
EMA 26
16.76
+0.72% from price
EMA 50
16.54
+2.08% from price
RSI (14)
51.6
Neutral
MACD (12,26,9)
0.29
Hist -0.10
ATR (14)
0.83
4.89% of price
Realised vol 30D
35.1%
Annualised
Bollinger upper
18.31
20, 2σ
Bollinger lower
15.49
20, 2σ
50 / 200 cross
Death
15.92 vs 18.44
Trend bias
Below 200
-8.45%

Options chain

Account required
ExpirySpot 16.88
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.14
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
35.1%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-61.3%
Peak to trough
Max drawdown 5Y
-79.6%
Peak to trough
ATR 14
0.83
4.89% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.